跳到正文
原文
Endpoints News 生物医药· ENDPOINTS·· 28 天前AI 评分26

Arbutus乙肝药物暂停审批解除、药品立项及Ultomiris加速获批

A hepatitis B hold lifted and drug tabled; Ultomiris' accelerated approval

AI 导读

Arbutus公司研发的乙肝药物被解除暂停审批状态,同时该药正式立项。Ultomiris获得加速批准。此外,文章还提及Biohaven、Arcus Sciences以及Boehringer Ingelheim与Microsoft的跨界合作动态。

正文

Plus news about Bio­haven, Ar­cus Bio­sciences and a Boehringer In­gel­heim and Mi­crosoft col­lab­o­ra­tion.

Hold on Ar­bu­tus drug lift­ed: It’s been a long, tough road for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news